Fig. 1From: A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s diseaseSurvey flow diagram illustrating the order of survey questions. Based on their responses, participants were instructed to proceed to specific sections of the survey (e.g., participants that did not wish to know their mutation status were instructed to complete only Section B) or to stop. AD Alzheimer’s diseaseBack to article page